Article Details

Affimed Initiates Patient Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in ...

Retrieved on: 2021-12-08 11:31:26

Tags for this article:

Click the tags to see associated articles and topics

Affimed Initiates Patient Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in .... View article details on HISWAI: https://www.globenewswire.com/news-release/2021/12/08/2348130/0/en/Affimed-Initiates-Patient-Recruitment-for-a-Phase-1-2a-Trial-of-Innate-Cell-Engager-AFM24-in-Combination-with-Roche-s-Anti-PD-L1-Checkpoint-Inhibitor-Atezolizumab.html

Excerpt

... Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in Combination with Roche's Anti-PD-L1 Checkpoint Inhibitor Atezolizumab.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up